NSE · APLLTD
Alembic Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#410
of 5,072 stocks
▲ 81W
Peak #410 · 27 Sep 2026
A midcap name in Healthcare, Alembic Pharmaceuticals Limited remains firmly promoter-controlled, with promoters holding 70%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
16,977.01 Cr
P/E Ratio
25.16
P/B Ratio
2.99
ROE
11.83%
ROCE
13.85%
Dividend Yield
1.39%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 2,149.77 Cr | 1,847.72 Cr | 1,876.31 Cr | 1,910.15 Cr |
| Net Profit | 172.36 Cr | 201.54 Cr | 131.95 Cr | 183.71 Cr |
| EPS | 8.80 | 10.31 | 6.76 | 9.40 |
| Operating Profit | 249.08 Cr | 164.84 Cr | 228.88 Cr | 246.53 Cr |
Shareholding pattern
Promoter
69.87%
Public
30.13%
PUBLIC BREAKDOWN
FII
4.18%
DII
15.94%
MF (within DII)
8.73%
Individuals
7.52%
Mutual fund holdings
₹1,412.43
Cr total
30
Schemes
11
Fund Houses
₹1,412.43 Cr
Total Exposure
DSP Mutual Fund₹502.82 Cr (35.6%)
ICICI Prudential Mutual Fund₹288.30 Cr (20.4%)
Kotak Mahindra Mutual Fund₹286.18 Cr (20.3%)
UTI Mutual Fund₹142.60 Cr (10.1%)
Axis Mutual Fund₹121.51 Cr (8.6%)
Others₹71.01 Cr (5.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 29 Jul 2026 | Dividend | Dividend - Rs 12 Per Share |
| 29 Jul 2025 | Dividend | Dividend - Rs 11 Per Share |
| 15 Jul 2024 | Dividend | Dividend - Rs 11 Per Share |
| 28 Jul 2023 | Dividend | Dividend - Rs 8 Per Share |
| 17 Aug 2022 | Dividend | Interim Dividend - Rs 10 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.